Atypical mood stabilizers : a 'typical' role for atypical antipsychotics

Malhi, G. S., Berk, M., Bourin, M., Ivanovski, B, Dodd, S., Lagopoulos, J. and Mitchell, P. B. 2005, Atypical mood stabilizers : a 'typical' role for atypical antipsychotics, Acta psychiatrica Scandinavica, vol. 111, no. 426, Supplement, pp. 29-38, doi: 10.1111/j.1600-0447.2005.00524.x.

Attached Files
Name Description MIMEType Size Downloads

Title Atypical mood stabilizers : a 'typical' role for atypical antipsychotics
Author(s) Malhi, G. S.
Berk, M.ORCID iD for Berk, M.
Bourin, M.
Ivanovski, B
Dodd, S.ORCID iD for Dodd, S.
Lagopoulos, J.
Mitchell, P. B.
Journal name Acta psychiatrica Scandinavica
Volume number 111
Issue number 426
Season Supplement
Start page 29
End page 38
Publisher Wiley-Blackwell Publishing
Place of publication Malden, Ma.
Publication date 2005-05
ISSN 0001-690X
Keyword(s) bipolar disorder
atypical antipsychotics
mood stabilizers
Summary Objective: To assess the potential role of atypical antipsychotics as mood stabilizers.

Method: A MedLine, PsychLIT, PubMed, and EMBASE literature search of papers published up to December 2004 was conducted using the names of atypical antipsychotics and a number of key terms relevant to bipolar disorder. Additional articles were retrieved by scrutinizing the bibliographies of review papers and literature known to the authors. Data pertinent to the objective was reviewed according to the various phases of bipolar disorder.

Results: The data is most substantive for the use of atypical antipsychotics in mania, to the extent that an argument for a class effect of significant efficacy can be made. This does not extend to bipolar depression, however, good data is now emerging for some agents and will need to be considered for each individual agent as it accumulates. As regards mixed states and rapid cycling the evidence is thus far sparse and too few maintenance studies have been conducted to make any firm assertions. However, with respect to long-term therapy the atypical antipsychotics do have clinically significant side-effects of which clinicians need to be aware.

Conclusion: Based on the evidence thus far it is perhaps premature to describe the atypical antipsychotics as mood stabilizers. Individual agents may eventually be able to claim this label, however, much further research is needed especially with respect to maintenance and relapse prevention.
Language eng
DOI 10.1111/j.1600-0447.2005.00524.x
Field of Research 119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©2005, Blackwell Munksgaard
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 23 times in TR Web of Science
Scopus Citation Count Cited 26 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 774 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Wed, 22 Jun 2011, 12:43:06 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact